A QALY is [still] a QALY is [still] a QALY?
| dc.contributor.author | Mahdiani, Hamideh | |
| dc.contributor.author | Münch, Nikolai | |
| dc.contributor.author | Paul, Norbert W. | |
| dc.date.accessioned | 2025-07-30T10:44:17Z | |
| dc.date.available | 2025-07-30T10:44:17Z | |
| dc.date.issued | 2024 | |
| dc.description.abstract | Despite clinical evidence of drug superiority, therapeutic modalities, like combination immunotherapy, are mostly considered cost-ineffective due to their high costs per life year(s) gained. This paper, taking an ethical stand, reevaluates the standard cost-effectiveness analysis with that of the more recent justice-enhanced methods and concludes by pointing out the shortcomings of the current methodologies. | en |
| dc.identifier.doi | https://doi.org/10.25358/openscience-12790 | |
| dc.identifier.uri | https://openscience.ub.uni-mainz.de/handle/20.500.12030/12811 | |
| dc.language.iso | eng | |
| dc.rights | CC-BY-4.0 | |
| dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | |
| dc.subject.ddc | 610 Medizin | de |
| dc.subject.ddc | 610 Medical sciences | en |
| dc.title | A QALY is [still] a QALY is [still] a QALY? | en |
| dc.type | Zeitschriftenaufsatz | |
| jgu.journal.title | BMC medical ethics | |
| jgu.journal.volume | 25 | |
| jgu.organisation.department | FB 04 Medizin | |
| jgu.organisation.name | Johannes Gutenberg-Universität Mainz | |
| jgu.organisation.number | 2700 | |
| jgu.organisation.place | Mainz | |
| jgu.organisation.ror | https://ror.org/023b0x485 | |
| jgu.pages.alternative | 35 | |
| jgu.publisher.doi | 10.1186/s12910-024-01036-w | |
| jgu.publisher.eissn | 1472-6939 | |
| jgu.publisher.name | BioMed Central | |
| jgu.publisher.place | London | |
| jgu.publisher.year | 2024 | |
| jgu.rights.accessrights | openAccess | |
| jgu.subject.ddccode | 610 | |
| jgu.subject.dfg | Lebenswissenschaften | |
| jgu.type.dinitype | Article | en_GB |
| jgu.type.resource | Text | |
| jgu.type.version | Published version |